UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055677
Receipt number R000063624
Scientific Title Impact of mechanical ventilation strategy with electrical impedance tomography in patients at high-risk of postoperative pulmonary complications: A randomized clinical study
Date of disclosure of the study information 2024/10/01
Last modified on 2026/02/05 13:31:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Impact of mechanical ventilation strategy with electrical impedance tomography in patients at high-risk of postoperative pulmonary complications: A randomized clinical study

Acronym

OSACA EIT TRIAL

Scientific Title

Impact of mechanical ventilation strategy with electrical impedance tomography in patients at high-risk of postoperative pulmonary complications: A randomized clinical study

Scientific Title:Acronym

Impact of mechanical ventilation strategy with electrical impedance tomography in patients at high-risk of postoperative pulmonary complications: A randomized clinical study

Region

Japan


Condition

Condition

Adult patients (18 years or older) undergoing elective cardiac surgery, requiring mechanical ventilation upon ICU admission postoperatively, and at high risk for postoperative respiratory complications(ARISCAT score >= 45).

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Many postoperative ICU patients require respiratory management with mechanical ventilation. However, it is known that inappropriate PEEP (Positive End-Expiratory Pressure) settings can cause dorsal atelectasis and ventral hyperinflation, leading to uneven ventilation distribution in the lungs. There is no established method for setting PEEP for patients requiring postoperative mechanical ventilation, and intensive care physicians typically set it empirically based on oxygenation.EIT (Electrical Impedance Tomography) is a device that can non-invasively monitor ventilation distribution in the lungs over time at the bedside without X-ray exposure. Our research using EIT has shown that in patients at high risk for postoperative respiratory complications, about 60% have uneven lung ventilation distribution with PEEP settings based on clinical judgment. We also found an association between uneven lung ventilation distribution and increased postoperative respiratory complications and prolonged mechanical ventilation time.
Therefore, the purpose of this study is to test the hypothesis that PEEP settings guided by EIT-based ventilation distribution indicators will result in decreased postoperative respiratory complication severity scores and shortened time to weaning from mechanical ventilation compared to conventional PEEP settings without EIT use in patients at high risk for postoperative respiratory complications.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

Proportion of patients with a postoperative pulmonary complication severity score >= 3

Key secondary outcomes

1.Time to liberation from mechanical ventilation
Definition of liberation from mechanical ventilation: The point at which the patient survives and is free from mechanical ventilation for 48 hours (maximum 90 days)
2.Time to cessation of oxygen therapy
Definition of cessation of oxygen therapy: The point at which the patient survives and is free from oxygen therapy for 48 hours (maximum 90 days)
3.Reintubation rate
4.Incidence of barotrauma
5.ICU length of stay
6.Hospital length of stay
7.Adverse events during ICU stay
8.Measured tidal volume (at allocation, 4 hours after allocation, immediately before extubation)
9.Measured respiratory rate (at allocation, 4 hours after allocation, immediately before extubation)
10.PEEP (at allocation, 4 hours after allocation, immediately before extubation)
11.Plateau pressure (at allocation, 4 hours after allocation, immediately before extubation)
12.Driving pressure (at allocation, 4 hours after allocation, immediately before extubation)
13.Static respiratory system compliance (at allocation, 4 hours after allocation, immediately before extubation)
14.A postoperative pulmonary complication severity score


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

EIT Use Group (Intervention):
- Mode: A/C
- Tidal volume: 6-10 mL/predicted body weight
- Respiratory rate: Target PaCO2 35-45 mmHg
- FiO2: Target SpO2 90-99%
- PEEP: Adjust for Dorsal Fraction of Ventilation (DFV) 0.5-0.59

PEEP setting:
1. Recruitment: 30 cmH2O for 20s (PEEP 15 cmH2O, inspiratory pressure 15 cmH2O)
2. Decrease PEEP by 2 cmH2O every 30s-2min from 15 cmH2O until DFV 0.5-0.59
3. PEEP range: 15-3 cmH2O
4. Adjust hourly if needed

Notes:
- Allow high PEEP if DFV >=0.6 at admission and oxygenation decreases
- Clinician discretion for settings if spontaneous breathing within 4 hours

Interventions/Control_2

Non-EIT Group (Control):
- Mode: A/C (volume or pressure)
- Tidal volume: 6-10 mL/predicted body weight
- Respiratory rate: Target PaCO2 35-45 mmHg
- FiO2: Target SpO2 90-99%
- PEEP:
PaO2/FiO2 >=300 mmHg: PEEP 5 cmH2O
PaO2/FiO2 200-299 mmHg: PEEP 6-10 cmH2O
PaO2/FiO2 <200 mmHg: PEEP 10-15 cmH2O

- Maintain set PEEP for >=4 hours
- Adjust other settings as needed within 4 hours
- Clinician discretion for spontaneous breathing
- Allow high PEEP for hemostasis pre-allocation
- Adjust PEEP if hemodynamically unstable

Notes:
- Set PEEP per criteria if >5.0 cmH2O at allocation
- Clinician discretion for settings if spontaneous breathing within 4 hours

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Patients aged 18 years or older who have undergone cardiac surgery
2.Patients receiving mechanical ventilation upon admission to the ICU after surgery
3.Patients at high risk for postoperative pulmonary complications*
*Definition of high-risk patients for postoperative pulmonary complications: ARISCAT score of 45 points or higher

Key exclusion criteria

Exclusion criteria:
1. Patients with contraindications for EIT:
- Unstable spine or pelvis due to fractures
- Implanted defibrillators or pacemakers
- Skin lesions at the 4th-5th intercostal space where the EIT belt is placed
- Patients who are unable to wear the EIT belt (if they have other items attached to the belt after thoracic and abdominal vascular replacement surgery)
2. Patients with DNR (do-not-resuscitate) orders
3. Patients on home mechanical ventilation pre-operatively
4. Patients with tracheostomy
5. Patients not planned for extubation in the ICU for elective surgery the following day or later
6. Patients with pre-existing low cardiac function (left ventricular ejection fraction <= 40% on echocardiography or NYHA class III or higher)
7. Patients with bullae identified on pre-operative chest CT or X-ray, contraindicating recruitment maneuvers
8. Patients with continuous air leaks from chest drains or suspected intraoperative lung injury, contraindicating recruitment maneuvers
9. Patients with ventricular assist devices
10. Patients on extracorporeal membrane oxygenation (VV or VA)
11. Patients with a history of neuromuscular diseases
12. Pregnant women
13. Patients who have undergone lung resection or lung transplantation
14. Patients undergoing emergency surgery where obtaining consent is difficult
15. Patients who are likely to be extubated within 4 hours after ICU admission
16. Patients whose hemodynamic stability cannot be confirmed within 12 hours after admission to the ICU

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Takeshi
Middle name
Last name Yoshida

Organization

Osaka University Hospital

Division name

Department of Anesthesiology and Intensive Care Medicine, Graduate School of Medicine, Osaka University

Zip code

565-0871

Address

2-15 Yamadaoka, Suita, Osaka

TEL

06-6879-5111

Email

takeshiyoshida@hp-icu.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name Takeshi
Middle name
Last name Yoshida

Organization

Osaka University Hospital

Division name

Department of Anesthesiology and Intensive Care Medicine, Graduate School of Medicine

Zip code

565-0871

Address

2-15 Yamadaoka, Suita, Osaka

TEL

06-6879-5111

Homepage URL


Email

takeshiyoshida@hp-icu.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee of Osaka University Hospital

Address

Research Support Section, Education and Research Support Division Osaka University Hospital 4th Floor, Center for Medical Innovation and Translational Research Building 2-2 Yamadaoka, Suita City

Tel

06-6210-8296

Email

rinri@hp-crc.med.osaka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院(大阪府)、大阪医科薬科大学病院(大阪府)、八尾徳洲会総合病院(大阪府)、神戸大学医学部附属病院(兵庫県)、広島大学病院(広島県)、藤田医科大学病院(愛知県)



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 09 Month 30 Day

Date of IRB

2024 Year 10 Month 07 Day

Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 09 Month 30 Day

Last modified on

2026 Year 02 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063624